Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Laser Tissue Resurfacing : Article by

Quick Find
Authors & Editors
Introduction
Indications
Relevant Anatomy
Contraindications
Treatment
Complications
Outcome and Prognosis
Future and Controversies
Multimedia
References




Patient Education
Click here for patient education.



Author: Adam J Cohen, MD, Assistant Professor, Department of Ophthalmology, Northwestern University Feinberg School of Medicine; Consulting Surgeon, Myers Wyse Center for the Eye; Director, Center for Facial Rejuvenation; Founding Partner, HC Consulting, Inc

Adam J Cohen is a member of the following medical societies: American Academy of Ophthalmology and American College of Surgeons

Coauthor(s): Samer Alaiti, MD, Clinical Assistant Professor, Departments of Dermatology and Internal Medicine, University of California at Los Angeles School of Medicine; Michael B Stevens, MD, PhD, Consulting Staff, Department of Plastic Surgery, Kaweah Delta Hospital

Editors: Stephen D Plager, MD, FACS, Chief, Department of Ophthalmology, Dominican Hospital; Assistant Clinical Professor, Department of Ophthalmology, Stanford University Hospital; Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles; Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal, and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Author and Editor Disclosure

Synonyms and related keywords: CO2 laser resurfacing, carbon dioxide laser resurfacing, cutaneous laser resurfacing, mechanical abrasion, chemical peeling

Until the advent of cutaneous laser resurfacing in the late 1980s, physicians had long utilized mechanical abrasion and a variety of chemical peeling agents to restore a youthful look to the aged face.

Some authors reported satisfactory resurfacing results with the use of continuous wave carbon dioxide lasers. This technique was not widely employed because of the significant thermal damage that accompanied the use of continuous wave lasers, which meant a high likelihood of potential scarring.

The application of short-pulsed, high-energy, scanned carbon dioxide lasers and other laser systems that limit skin heating have revolutionized laser resurfacing.



Recognition of suitable candidates for carbon dioxide laser resurfacing is of paramount importance to avoid undesired outcomes. Generally, middle-aged patients (40-65 y) with fair skin and fine-to-moderate static (nondynamic) wrinkles are ideal candidates. Selecting patients with realistic expectations (those who seek improvement, not complete eradication of wrinkles or scars) is important.

Rhytids

Carbon dioxide laser resurfacing (as the sole treatment) can achieve excellent results in patients with mild-to-moderate surface texture changes and fine superficial or moderate static wrinkles (not deep furrows or severe dermatoheliosis, see Image 1). Carbon dioxide laser resurfacing combined with botulinum toxin A (BOTOX®, Allergan) for dynamic rhytids, or with cervicofacial rhytidectomy and/or blepharoplasty or eyebrow lifting, can also result in excellent aesthetic improvement.

Scars

Acne scars can be classified into 3 basic types: shallow depressed scars, wide-base atrophic scars, and ice-pick scars. The first 2 types of acne scars are generally amenable to carbon dioxide laser resurfacing. Fibrotic or ice-pick scars often require punch excision, punch grafts, or punch elevation. Scar-base lifting and injection of filling substances for atrophic acne scars (completed as a separate procedure at a different time) can be combined with laser resurfacing for optimal results. Varicella and smallpox scars may also be improved with carbon dioxide laser resurfacing.

Dermatoheliosis

Carbon dioxide laser resurfacing is a valuable tool for facial rejuvenation of photodamaged skin. Improvement of fine lines and wrinkles, dyspigmentation, rough skin texture, and solar lentigines, along with eradication of premalignant tumefactions, such as actinic keratoses, can be achieved. Prevention of actinic keratosis development has not been substantiated with carbon dioxide resurfacing.

Other indications

Other indications for carbon dioxide laser skin resurfacing include the following:

  • Seborrheic keratosis
  • Verruca vulgaris/plana
  • Sebaceous gland hyperplasia
  • Angiofibroma (fibrous papule of the nose)
  • Junctional and compound nevi
  • Lentigo simplex
  • Small syringomas
  • Epidermal melasma
  • Rhinophyma



Extensive knowledge of skin microanatomy, histology, physiology, and function is essential before proceeding with resurfacing procedures. Familiarity with relative facial skin thickness (ie, thin, medium, thick) is salutary to avoid overtreatment and potential complications.



Contraindications to carbon dioxide laser skin resurfacing include the following:

  • Absolute
    • Active bacterial, viral, or fungal infections
    • Tendency for keloid or hypertrophic scar formation
    • Unrealistic expectations
    • Uncooperative patient
  • Relative
    • Poor general health
    • Oral isotretinoin (Accutane, Roche) use within the previous 12 months
    • Fitzpatrick skin photo types 5-6
    • Reticular dermis-level resurfacing procedure within the preceding 2-3 months
    • Unwillingness to accept the possibility of postoperative erythema or hypopigmentation
    • Significant eyelid laxity
    • Excessively thick or thin skin
    • Collagen vascular disease, HIV, or hepatitis C infection



Preoperative details

  • Specific attention should be given to skin type and the degree of photodamage.
    • The Obagi skin classification is probably the most comprehensive skin classification system, and it analyzes the skin using the following criteria:
      • Skin color - Original (light white, dark black, dark Asian), deviated (brunette, white, light black, medium black, light Asian, medium Asian, and complex skin)
      • Skin thickness - Thick, thin, medium
      • Skin firmness - Firm versus lax
      • Skin fragility - Tough versus fragile
      • Skin oiliness - Oily, normal, dry
    • Carbon dioxide laser resurfacing is not recommended for any skin color other than light white, white, or brunette.
    • Excessively thick or thin skin is a relative contraindication to this procedure.
    • The degree of photoaging can be assessed by judging the degree of wrinkling, the number of actinic keratosis and seborrheic keratosis, solar elastosis, senile comedones, telangiectasia, yellowish discoloration, mottled hyperpigmentation, and skin laxity.
    • In general, patients with early photodamage do not require carbon dioxide laser resurfacing. The ideal patient has mild-to-moderate photoaging.
  • History of herpes labialis infection: Suppressive therapy with oral antiviral medications should start 1-2 days before the procedure and continue until complete reepithelialization takes place.
  • History of frequent vaginal candidal infections: Affected patients should be given a prophylactic course of oral antifungal medications.
  • Paucity of adnexal structures (skin poor in pores, hair follicles, and oily glands): This can occur in some skin types as an idiopathic phenomenon, or it can be related to a previous deep resurfacing procedure or radiation therapy.
  • Significant lower eyelid laxity: Aggressive carbon dioxide laser resurfacing should be avoided on the lid proper to avoid post resurfacing eyelid retraction, cicatricial ectropion, and lagophthalmos.
  • The author starts all patients on a daily skin-conditioning regimen at least 6 weeks before carbon dioxide laser skin resurfacing. The regimen consists of the following:
    • Retinoic acid 0.05-0.1% cream (Retin-A, Ortho Dermatological) 0.5-1 g in the evening.
    • Hydroquinone 2-4% cream (Clear, Obagi Medical Products, or Eldoquin Forte, ICN Pharmaceuticals) 0.5-1 g twice daily in the morning and evening; it is not necessary to use hydroquinone on patients who are light white (Fitzpatrick phototype 1).
    • Alpha-hydroxy acids 2-4% cream (Exfoderm, Obagi Medical Products) 0.5-1 g in the morning.
    • Sun protection (SPF 15 or higher) (Sunfader or Sunblock, Obagi Medical Products) in the morning
  • Patients with realistic expectations should be selected. Avoid patients with psychological instability; they may not be able to withstand the posttreatment course and any potential complications.
  • Any allergies to anesthetics should be investigated properly.
  • Patients should wash the face with an antibacterial soap the night before and the morning prior to laser treatment.

Intraoperative details

Laser tissue interaction

Carbon dioxide laser emits light at a wavelength of 10,600 nm, which is strongly absorbed by water (the primary chromophore for carbon dioxide light that is abundant in the skin).

Although approximately 90% of the carbon dioxide laser energy is absorbed by the initial 20-30 µm of skin, traditional continuous wave lasers leave behind a thick zone of thermal damage measuring 0.2-1 mm in thickness.

The theory of selective photothermolysis states that selective heating of the target chromophore can be achieved when using laser pulses shorter than the thermal relaxation time (TRT) of the chromophore (the time that it takes the chromophore to loose 50% of its heat to the surrounding tissue). The TRT for 20-30 µm of skin tissue is about 1 millisecond.

By using the theory of selective photothermolysis, carbon dioxide lasers with a pulse duration of less than 1 millisecond are capable of selectively vaporizing tissue with only a very thin zone of residual thermal necrosis measuring about 100 µm.

To have a clinical effect in the skin, laser energy must be absorbed by the target chromophore.

It was determined that the energy fluence (density) necessary to vaporize tissue is approximately 5 joules/cm2 (ablation threshold). Overall, delivering a 1-millisecond carbon dioxide laser pulse with an energy fluence of approximately 5 joules/cm2 leads to tissue vaporization measuring 20-30 µm and residual thermal injury measuring 40-120 µm.

This zone of thermal necrosis is sufficient to seal small dermal blood vessels and lymphatics, yet narrow enough to reduce the incidence of scarring.

Laser technology and systems

Basically, 2 different types of carbon dioxide lasers are promoted for the purpose of skin resurfacing. The first is a high-power, pulsed carbon dioxide laser that can deliver approximately 500 millijoules of energy in each submillisecond pulse resulting in energy fluence measuring 5-7 joules/cm2. Some of these systems have a computerized pattern generator (CPG) that can rapidly and precisely place individual laser pulses in several different patterns. The other type uses an optomechanical flash scanner connected to a conventional continuous wave carbon dioxide laser. This scanner can efficiently distribute the laser energy into a train of pulses with a dwell time shorter than the skin TRT, thus mimicking truly pulsed carbon dioxide lasers.

Recently, carbon dioxide resurfacing lasers with very short pulse duration (60 microseconds) have emerged. They ablate less tissue per pass and leave behind a narrower zone of thermal necrosis compared with the original carbon dioxide resurfacing lasers. All of the above laser systems appear to be equally effective in skin resurfacing when they achieve similar depths of skin injury.

Follow-up

  • Close monitoring of patients during the postoperative period is essential. Patients should be followed up frequently and at close intervals to provide the much-needed support, and to detect any complications early in the course.
  • Recovery for full-face laser resurfacing takes 7-14 days; it mainly depends on the depth achieved. During the first week, patients experience variable degrees of oozing and crusting depending on the dressing used. Dressings should be applied until complete reepithelialization takes place; then, the patient can start applying a light water-based moisturizer for the next 2-3 weeks.
  • Postprocedure skin reconditioning should begin early during the healing process. Hydroquinone and retinoic acid can be reintroduced 3-4 weeks postoperatively. Alpha-hydroxy acids should be avoided until the stratum corneum is fully regenerated and skin tolerance has returned. Sunscreens can be used once reepithelialization takes place.
  • Patients should be evaluated at 2-3 days, 1 week, 3-4 weeks, 3 months, 6 months, and 1 year after resurfacing.



Similar to all other resurfacing modalities, the incidence of complications following carbon dioxide laser resurfacing primarily is related to the depth attained.

Expected sequelae commonly encountered after carbon dioxide laser resurfacing must be clearly differentiated from true complications. Sequelae include the following:

  • Swelling
    • Post–re-surfacing swelling is expected; it peaks at days 2 or 3 and usually subsides by days 5-7.
    • Intravenous betamethasone intraoperatively and a course of oral prednisone postoperatively for 5 days can significantly help in decreasing the swelling.
  • Erythema
    • Erythema, to some degree, is seen in all patients who had been resurfaced to the level of the upper dermis with carbon dioxide laser. It is related to increased blood flow, collagen remodeling, inflammation, and increased metabolic activity.
    • Erythema is more obvious in patients with lighter skin complexion and patients with flushing or blushing tendency such as in acne rosacea.
    • While erythema usually is transient, it may persist for weeks to months but generally can be camouflaged with green- or yellow-tinted makeup.
    • Topical steroids should not be used to treat post–re-surfacing erythema because they reduce collagen synthesis.
    • Carbon dioxide lasers that do not induce erythema have only produced superficial injury, and the procedure will not induce collagen remodeling.
    • The diffuse erythema of laser resurfacing should be differentiated from focal, itchy, palpable, or persistent erythema, which is a sign of a developing hypertrophic scar or keloid.
  • Itching (pruritus)
    • Although itching is common after laser resurfacing, it could signal infection, contact dermatitis, or early scarring.
    • In the absence of these conditions, pruritus responds to an oral antihistamine or midpotency topical steroid (eg, mometasone furoate 0.1%, Elocon, Schering).
  • Acne flare/milia
    • Milia and acne commonly are seen 2-4 weeks after carbon dioxide laser resurfacing and are partially related to the use of occlusive ointments.
    • Many of these patients are acne prone to start with, and can be significantly improved with re-introducing retinoic acid and topical antibiotics to their post–re-surfacing regimen.
    • Additionally, a 2-3 month course of oral antibiotics (eg, tetracycline, Achromycin V, Lederle Labs) or oral isotretinoin usually is very helpful.
    • Comedones and milia can be expressed manually using a comedo extractor.
  • Post–re-surfacing hyperpigmentation
    • Hyperpigmentation after resurfacing is common, especially in patients with dark skin. Usually, it is seen first 14-21 days after the procedure and represents a postinflammatory hyperpigmentation phenomenon.
    • Preconditioning the skin prior to carbon dioxide resurfacing with retinoic acid and hydroquinone decreases the incidence, severity, and duration of the hyperpigmentation. Any resulting hyperpigmentation may be more amenable to therapy.
    • Aggressive post–re-surfacing skin reconditioning using hydroquinone 2-4% bid, retinoic acid (0.5-0.1%) qhs, sun protection, and sunscreen leads to resolution of this condition in 2-4 weeks.

Complications include the following:

  • Infection (bacterial, viral, yeast, fungal)
    • A typical presentation would be a papulopustular eruption with itching or pain and delayed healing.
    • Sometimes, infection can present as maceration and necrotic tissue in a previously healed area.
    • Lesions should be cultured using the appropriate medium (viral, bacterial, fungal).
    • Appropriate topical and systemic medications should be started as soon as possible.
  • Contact dermatitis
    • Irritant or allergic contact dermatitis may be secondary to topical antibiotics, moisturizers, or cleansers.
    • Dermatitis can be treated successfully with potent topical corticosteroids (eg, clobetasol propionate 0.05%, Temovate, Glaxo-Wellcome).
    • Systemic steroids rarely are needed.
  • Hypopigmentation (see Image 3)
    • The occurrence of hypopigmentation relates to the depth of resurfacing and resultant thermal injury. It usually occurs in darker skin types, and is seen 6-12 months after resurfacing.
    • This complication can be avoided by the following: avoiding regional resurfacing (especially in darker individuals), limiting the resurfacing depth to the papillary dermis or upper reticular dermis, and stimulating the skin to regenerate pigment in the epidermis by recruiting the melanocytes in the adnexal structures, which can be attempted by using retinoic acid every night.
  • Sharp demarcation lines can be avoided by the following:
    • Creating a transitional zone of resurfaced skin (ie, gradual depth change of resurfacing between face and neck).
    • Combining full-face resurfacing with a light chemical peel such as a 15-20% trichloroacetic acid peel (TCA) on the neck. This creates a less noticeable gradient zone between the face and neck.
  • Hypertrophic scars and keloids
    • Scar formation is strongly related to the following: depth of resurfacing, development of infection, and postoperative wound care. It is seen more commonly in nonfacial skin resurfacing.
    • Any localized persistent erythema with or without pruritus should be considered an evolving hypertrophic scar until proven otherwise.
    • Aggressive treatment with high potency topical steroids (eg, clobetasol propionate 0.05%, Temovate, Glaxo Wellcome), intralesional steroids (eg, triamcinolone acetonide 10 mg/mL, Aristocort, Fugisawa), 5-fluorouracil or verapamil, silicone gel sheeting and flash lamp, pulsed dye, and laser therapy are very helpful.
  • Ectropion, eyelid retraction, and lagophthalmos
    • Ectropion usually is related to aggressive carbon dioxide laser resurfacing of the lower eyelids, pre-existing laxity of the lower lids, preexisting skin excision during blepharoplasty, or development of an infection.
    • Ectropion can be avoided by testing the lid for laxity before resurfacing and by limiting the depth of resurfacing on the eyelids to the papillary dermis.
    • If ectropion develops, using eye lubricants, upward massaging of the lower eyelid, and prescribing a potent steroid cream can help reverse the malpositioned eyelid and prevent cicatrix formation.
    • In some cases of ectropion, surgery is necessary to restore normal eyelid position.
  • Tooth enamel injury can be avoided by proper protection.
  • Thermal eye injuries can be avoided by using the eye shields. Particular emphasis is placed on choosing the correct size and applying copious eye lubricants prior to inserting the metal shields.



The results of laser resurfacing are good to excellent, depending on the indication for which the procedure was performed. Patient satisfaction is based on the delivery of natural results with minimal downtime and a low incidence of complications. Actinic changes are improved to the greatest degree. Typically, wrinkles are improved by 60-80%, while scars are improved to a lesser degree. Improvement can be seen in deeper skin folds of the cheeks, forehead and neck, malar bags, and even in the excess skin of the upper eyelid (pseudoblepharoplasty effect), but their improvement are less predictable. Static lines are improved to a greater degree than dynamic lines. Treatment of these dynamic lines with botulinum toxin A provides significant improvement.

To best estimate the degree of improvement after healing is complete, results should be assessed at 6 months after resurfacing. Usually, some loss of early improvement and some recurrence of wrinkles can be seen as postoperative edema resolves. Repeat treatments are possible but should be spaced approximately 6 months apart. Laser skin resurfacing is relatively a new procedure, and long-term skin effects are largely unknown.

Overall success in laser skin resurfacing is related to the following: proper patient and skin type selection; attention to preoperative, intraoperative, and postoperative details; aggressive management of emerging complications; and good patient-physician relationship.



In general, given the overall success and safety of carbon dioxide laser resurfacing, the demand for this procedure will continue to increase at a relatively notable speed. Every resurfacing procedure (eg, lasers, peels, dermabrasion) has specific indications for which it is the procedure of choice. Each procedure has inherent advantages and disadvantages; therefore, making the choice of whether to use one resurfacing procedure or another procedure is sometimes difficult. Choice of resurfacing modality certainly depends on the physician's skills in regards to that procedure and the patient's needs. Furthermore, it is unknown if the long-term results of various resurfacing procedures differ if the depth achieved was equal. Certainly, what gives carbon dioxide laser resurfacing an advantage over other resurfacing procedures is the precise control over the depth of tissue ablated.

Combined resurfacing modalities

Realizing that different regions of the face display various degrees of skin damage, there is often a need to combine more than one resurfacing modality to achieve the best result possible. A common example is a patient with deeper rhytids around the eyes and mouth but without many wrinkles on the rest of the face. To achieve good improvement in these wrinkles, a papillary or reticular dermis level of resurfacing is needed. However, there is no need to subject the rest of the face to this same depth of resurfacing; an upper papillary dermis-level procedure or even epidermal exfoliation may be all that is needed in these areas. In this case, periorbital and perioral carbon dioxide laser resurfacing can be combined with a more superficial TCA peel such as the Blue Peel (15-20% TCA) over the rest of the face. This helps to blend the results better and to prevent any lines of demarcation.

While carbon dioxide laser resurfacing of undermined skin such as a rhytidectomy flap is controversial, carbon dioxide laser resurfacing can be performed safely on nonundermined skin and combined with a superficial TCA peel such as the Blue Peel (15-20% TCA) over the undermined skin flap if the depth of the peel is kept superficial (see Images 4-5).

Newer resurfacing modalities

Three resurfacing modalities recently have emerged with claims of achieving faster healing and less potential for complications than carbon dioxide laser resurfacing.

The erbium:Yttrium-aluminum-garnet (Er:YAG) laser has a wavelength of 2940 nm and a pulse duration of 250-500 microseconds. Because of greater water absorption, the Er:YAG laser ablates less tissue per pass (approximately 4-5 µm) with a narrower zone of thermal necrosis (approximately 20-30 µm) than the carbon dioxide laser. The Er:YAG laser can neither induce the same collagen tightening nor impart the hemostasis commonly seen with carbon dioxide laser. It is most suitable for exfoliation (epidermis level) or papillary dermis-level resurfacing (pinpoint bleeding as an endpoint), and it may not be as effective when used to correct deeper wrinkles or scars.

The neodynium:YAG laser (Nd:YAG) has a wavelength of 1320 nm. It can induce a certain degree of thermal collagen coagulation in the papillary dermis, while generally sparing the epidermis (nonablative resurfacing). The coagulation necrosis in the papillary dermis leads to collagen contracture and subsequent neo-collagenesis. This procedure is suited best for mild wrinkles. Multiple treatments are required over many weeks to achieve an optimal result.

Nonablative skin resurfacing modalities, such as the Fraxel SR laser (Reliant Technologies, Inc, Mountain View, Calif) and intense pulsed light (IPL), are newer technologies offering few adverse effects.



Media file 1:  Laser tissue resurfacing. A female patient with advanced dermatoheliosis and skin laxity.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Patient in Image 1 was treated with full-face, laser resurfacing with UltraPulse carbon dioxide laser. This photograph was taken 6 months after the treatment.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Depigmentation seen periorbitally, periorally, and on the forehead following carbon dioxide laser resurfacing.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 4:  Laser tissue resurfacing. Female patient with skin and muscle laxity, photoaging, and dermatochalasis.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 5:  Patient in Image 4 underwent combined upper and lower laser blepharoplasty, perioral and periorbital carbon dioxide laser resurfacing, SMAS facelift, and full-face blue peel. This photograph was taken 6 months after the procedure.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Alster TS. Cutaneous laser resurfacing: what's hot. Cosmetic Dermatol. October 1999;18-23.
  • Felder DS. CO2 laser skin resurfacing in oculoplastic surgery. Curr Opin Ophthalmol. Oct 1996;7(5):32-7. [Medline].
  • Fulton JE, Rahimi AD, Helton P, et al. Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg. Sep 1999;25(9):729-32. [Medline].
  • Harris DM, Fried D, Reinisch L, et al. Eyelid resurfacing. Lasers Surg Med. 1999;25(2):107-22. [Medline].
  • Ho C, Nguyen Q, Lowe NJ, et al. Laser resurfacing in pigmented skin. Dermatol Surg. Dec 1995;21(12):1035-7. [Medline].
  • Horton S, Alster TS. Preoperative and postoperative considerations for carbon dioxide laser resurfacing. Cutis. Dec 1999;64(6):399-406. [Medline].
  • Kilmer SL. Laser treatment of tattoos. Dermatol Clin. Jul 1997;15(3):409-17. [Medline].
  • Railan D, Kilmer S. Ablative treatment of photoaging. Dermatol Ther. May-Jun 2005;18(3):227-41. [Medline].
  • Ross EV, Grossman MC, Duke D, Grevelink JM. Long-term results after CO2 laser skin resurfacing: a comparison of scanned and pulsed systems. J Am Acad Dermatol. Nov 1997;37(5 Pt 1):709-18. [Medline].
  • Trelles MA, Rigau J, Mellor TK, Garcia L. A clinical and histological comparison of flashscanning versus pulsed technology in carbon dioxide laser facial skin resurfacing. Dermatol Surg. Jan 1998;24(1):43-9. [Medline].
  • Trelles MA, Mordon S, Svaasand LO, et al. The origin and role of erythema after carbon dioxide laser resurfacing. A clinical and histological study. Dermatol Surg. Jan 1998;24(1):25-9. [Medline].

Laser Tissue Resurfacing excerpt

Article Last Updated: Jun 19, 2006